Pyrazines
TARGETMOL CHEMICALS INC WS3 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. WS3 a (beta) cell proliferation inducer regulates Erb3 binding protein-1 (EBP1) and the I(kappa)B kinase pathway. purity: 98%
TARGETMOL CHEMICALS INC GINSENOSIDE F1 25MG
Also available in 5 mg 10 mg 50 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Ginsenoside F1 (20(S)-Ginsenoside F1) is an enzymatically modified derivative of ginsenoside Rg1 showing competitive inhibition of the activity of CYP3A4 and a weaker inhibition of the activity of CYP2D6. purity: 99%
![eMolecules 4042-36-8 | D-Pyr-OH | Ambeed | MFCD00066212 | 129.115 | C5H7NO3 | 98.000 | OC(=O)[C@H]1CCC(=O)N1 | 10g | 490520953](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502422108.JPG-250.jpg)
eMolecules 4042-36-8 | D-Pyr-OH | Ambeed | MFCD00066212 | 129.115 | C5H7NO3 | 98.000 | OC(=O)[C@H]1CCC(=O)N1 | 10g | 490520953
D-Pyr-OH | Ambeed | 4042-36-8 | MFCD00066212 | 129.115 | C5H7NO3 | 98.000 | OC(=O)[C@H]1CCC(=O)N1 | 10g | 490520953
![eMolecules 37784-17-1 | Boc-D-Pro-OH | Ambeed | MFCD00063226 | 215.249 | C10H17NO4 | 97.000 | CC(C)(C)OC(=O)N1CCC[C@@H]1C(O)=O | 10g | 528568263](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502422611.PNG-250.jpg)
eMolecules 37784-17-1 | Boc-D-Pro-OH | Ambeed | MFCD00063226 | 215.249 | C10H17NO4 | 97.000 | CC(C)(C)OC(=O)N1CCC[C@@H]1C(O)=O | 10g | 528568263
Boc-D-Pro-OH | Ambeed | 37784-17-1 | MFCD00063226 | 215.249 | C10H17NO4 | 97.000 | CC(C)(C)OC(=O)N1CCC[C@@H]1C(O)=O | 10g | 528568263
eMolecules 161611-46-7 | Ambeed | Ethyl 6-chloropyrazine-2-carboxylate | 1g | 525183968 | A317320 | MFCD16036493 | 186.6 | C7H7ClN2O2
Ambeed | 2-((4-Methoxybenzyl)oxy)-5-(4455-tetramethyl-132-dioxaborolan-2-yl)pyrimidine | 250mg | 752810142 | A1511768 | 2247982-62-1 | 342.200 | C18H23BN2O4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
TARGETMOL CHEMICALS INC PBRM1-BD2-IN-5 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. PBRM1-BD2-IN-5 is a potent PBRM1 Bromodomain inhibitor with Kd values of 1.5 uM and 3.9 uM for PBRM1-BD2 and PBRM1-BD5 respectively and an IC50 value of 0.26 uM for PBRM1-BD2. PBRM1-BD2-IN-5 reduces the binding of full-length PBRM1 within the PBAF complex in cell lysates to acetylated histone peptide. PBRM1-BD2-IN-5 can be used to research anticancer. purity: 99%
eMolecules 78056-60-7 | 1-Acetyl-4-piperidineacetic acid | Combi-Blocks | MFCD12027293 | 185.223 | C9H15NO3 | 97.000 | CC(=O)N1CCC(CC(O)=O)CC1 | 25g | 401040348
1-Acetyl-4-piperidineacetic acid | Combi-Blocks | 78056-60-7 | MFCD12027293 | 185.223 | C9H15NO3 | 97.000 | CC(=O)N1CCC(CC(O)=O)CC1 | 25g | 401040348
STEMCELL Technologies UNC0224
Histone modifier; Inhibits euchromatic histone methyltransferase 1 (EHMT1) and 2 (EHMT2) - 5 Mg
TARGETMOL CHEMICALS INC SIMEPREVIR 50MG
Also available in 2 mg 5 mg 10 mg 25 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Simeprevir (TMC435) is a potent HCV NS3/4A protease inhibitor and inhibits HCV replication with EC50 of 8 nM. purity: 99%
TARGETMOL CHEMICALS INC A-437203 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. A-437203 (Lu201640) is A kind of based on 1 h - pyrimidin - 2 - one sca ff old selective new powerful d3 receptor antagonist on D2 d3 and D4 receptor Ki value 71 respectively 1.6 and 6220 nM. purity: 98%
Matrix Scientific QUINOXALINE-2-CARBOXYLIC AC-1G
Quinoxaline-2-carboxylic acid, 97%; 1g,C9H6N2O2, MFCD00012334, mw 174.16, [879-65-2]
Aobchem (2-(Cyclopropylmethoxy)-3-methylphenyl)(methyl)sulfane | 95% | C12H16OS | 1g
(2-(Cyclopropylmethoxy)-3-methylphenyl)(methyl)sulfane | 95% | C12H16OS | 1g
TARGETMOL CHEMICALS INC LORLATINIB 25MG
Also available in 2 mg 5 mg 10 mg 50 mg 100 mg 1000 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Lorlatinib (PF-6463922) is an orally available ATP-competitive inhibitor of the receptor tyrosine kinases anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1) with potential antineoplastic activity. purity: 99%
Aobchem 2-(2-(Cyclopropylmethoxy)-3-(trifluoromethyl)phenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | 95% | C17H22BF3O3 | 1g
2-(2-(Cyclopropylmethoxy)-3-(trifluoromethyl)phenyl)-4 4 5 5-tetramethyl-1 3 2-dioxaborolane | 95% | C17H22BF3O3 | 1g